A comprehensive pan-cancer analysis of LRFN4: its potential as a prognostic biomarker and therapeutic target for immunotherapy
These findings suggest that LRFN4 may serve as a novel biomarker for cancer prognosis and a potential target for immunotherapy.
Authors
- Zhi Peng (ORCID: https://orcid.org/0000-0002-3690-5018)
- Lukuan You
- Yu Xu (ORCID: https://orcid.org/0000-0001-6898-4307)
- Siyuan Huai
- Ying Fu (ORCID: https://orcid.org/0000-0003-1177-0871)
- Xin Wu (ORCID: https://orcid.org/0009-0008-2292-4534)
- Gang Guo (ORCID: https://orcid.org/0000-0002-2562-8289)
- Jianxiong Li (ORCID: https://orcid.org/0000-0002-1675-7003)
Institutions
- Chinese General Hospital College of Nursing and Liberal Arts (PH)
- People's Liberation Army No. 150 Hospital (CN)
- Hainan 301 Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2025-05-02
- DOI
- https://doi.org/10.3389/fimmu.2025.1539076
- Primary Topic
- Ferroptosis and cancer prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00